What is Teal Health?
At-home cervical cancer screening platform anchored by the FDA-authorized Teal Wand.
- Category
- Women's preventive health
- Headquarters
- San Francisco, CA
- Founded
- 2020
- Employees
- 51-200 reported range
- Total funding
- $23M disclosed
- Status
- Private; commercial launch
What is Teal Health?
Teal Health is a women's preventive health company. Teal received FDA authorization in 2025 for at-home self-collection cervical cancer screening and announced nationwide expansion in January 2026.
Teal Health is a women's preventive health company with headquarters listed as San Francisco, CA. At-home cervical cancer screening platform anchored by the FDA-authorized Teal Wand. Teal received FDA authorization in 2025 for at-home self-collection cervical cancer screening and announced nationwide expansion in January 2026.
The company is currently best read as Private; commercial launch. Public sources show $23M disclosed in funding and Not publicly disclosed; where revenue, ARR, margin, or exact customer counts are not published, this profile avoids inventing them and uses funding, footprint, product coverage, and public scale signals instead.
For sellers, the account matters because buying centers span clinical operations, compliance, product, data, security, finance, and growth. The strongest pitch is tied to measurable access, quality, cost, workflow, or workforce outcomes rather than generic software adoption.
Sources:Teal homepageTeal FDA approval
What does Teal Health offer?
Teal Health offers Teal Wand, At-home HPV sample collection, Telehealth eligibility review, Lab processing, and related workflows.
- Teal Wand· Core product
- At-home HPV sample collection· Core product
- Telehealth eligibility review· Care workflow
- Lab processing· Care workflow
- Provider result review· Expansion
- Referral coordination· Expansion
Sources:Teal homepageTeal FDA approval
How does Teal Health make money?
Teal monetizes prescribed at-home screening, telehealth provider review, lab testing, care coordination, and insurance-covered preventive-care workflows.
Teal monetizes prescribed at-home screening, telehealth provider review, lab testing, care coordination, and insurance-covered preventive-care workflows.
Public pricing varies by coverage and eligibility; the Teal Wand is a prescription device ordered through Teal's telehealth workflow rather than a simple retail kit. Growth is driven by adoption in women's preventive health, expansion into larger accounts or additional geographies, and proof that the product improves outcomes, cost, capacity, or experience.
Because the company is private, this profile does not invent revenue, gross margin, or unit economics. Sellers should qualify budget owner, reimbursement model, procurement path, compliance requirements, and integration effort early.
Sources:Teal homepageTeal FDA approval
Who leads Teal Health?
Teal Health is led by Kara Egan, Avnesh Thakor, MD, PhD, Clinical provider team.
- Kara EganCo-founder & CEOSince 2020Leads commercialization of Teal's cervical-cancer screening platform.
- Avnesh Thakor, MD, PhDCo-founderFounderStanford professor and interventional radiologist behind the device concept.
- Clinical provider teamTelehealth and follow-up careCurrent care teamOwns eligibility, results review, and referral coordination.
How do you contact Teal Health's leadership?
Teal Health does not publish verified personal executive emails in the reviewed public sources. Use official company contact, demo, support, partnerships, or careers routes rather than guessed personal emails.
Personal executive email format not verified; use official company routingSources:Teal homepageTeal FDA approval
How much funding has Teal Health raised?
Teal Health has $23M disclosed in public or reported funding; latest disclosed round: Jan 2025 Seed extension ($10M).
Teal Health's disclosed funding history is: Jan 2023 Seed: $8.8M, valuation not disclosed, led/backed by Emerson Collective, Serena Ventures, Metrodora, Felicis; Jan 2025 Seed extension: $10M, valuation not disclosed, led/backed by Forerunner Ventures, Emerson Collective, and others.
The latest public valuation/status used here is Not publicly disclosed. If a valuation is not disclosed, this profile treats the company as private with no public priced mark rather than inferring a number from round size.
Seller signal: funding indicates capacity to invest, but healthcare buyers still require security, compliance, implementation proof, and outcomes evidence. New capital is most likely to support market expansion, hiring, product development, clinical operations, data, AI, and partnerships.
How did Teal Health get here?
Teal Health reached its current stage through founding, product expansion, and major financing milestones.
- 2020Company formationKara Egan begins building Teal Health.
- 2023$8.8M seedTeal raises seed funding for cervical-cancer screening access.
- Jan 2025$10M raiseTeal brings total funding to $23M before launch.
- May 2025FDA authorizationThe FDA authorizes the Teal Wand for at-home self-collection.
- Jan 2026Nationwide expansionTeal announces availability across all 50 states.
Sources:Teal homepageTeal FDA approval
Who are Teal Health's competitors?
Teal Health competes with adjacent healthcare providers, software platforms, marketplaces, and care-navigation companies.
- EverlywellAt-home lab testing marketplace with women's health tests.
- NurxTelehealth platform for sexual and reproductive health.
- WispTelehealth and pharmacy platform for sexual and reproductive care.
- LetsGetCheckedAt-home diagnostics and virtual care platform.
- TBD HealthSexual-health testing and care platform.
Sources:Teal homepageTeal FDA approval
Teal Health — frequently asked questions
